SCHEMBL30142782

SCHEMBL30142782

CCCCNc1ccc(C(=O)Nc2ncc([N+](=O)[O-])s2)c(-c2ccccc2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 5/20 0.52
▸ TNF P01375 1/20 0.52
▸ NOD2 Q9HC29 1/20 0.52
▸ NOD1 Q9Y239 1/20 0.52
▸ MEN1 O00255 7/20 0.51
▸ KMT2A Q03164 7/20 0.51
▸ NPC1 O15118 5/20 0.51
▸ RAB9A P51151 5/20 0.51
▸ POLB P06746 1/20 0.51
▸ LMNA P02545 4/20 0.50
▸ MAPT P10636 6/20 0.49
▸ ALDH1A1 P00352 4/20 0.49
▸ HTT P42858 3/20 0.49
▸ NPSR1 Q6W5P4 3/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ MLNR O43193 1/20 0.49
▸ NR1I2 O75469 1/20 0.49
▸ ABCB11 O95342 1/20 0.49
▸ TP53 P04637 1/20 0.49
▸ ADRB2 P07550 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29056948 1.00 STAT3 (0.52) STAT3TNFNOD2NOD1MEN1
SCHEMBL27135948 0.87 STAT3 (0.52) STAT3TNFNOD2NOD1MEN1
SCHEMBL30142800 0.86 KDR (0.52) CDK2
SCHEMBL25063073 0.86 STAT3 (0.58) STAT3MEN1KMT2ANPC1RAB9A
SCHEMBL24074165 0.86 ALDH1A1 (0.48) MEN1KMT2ANPC1RAB9ALMNA
SCHEMBL24074003 0.86 KDR (0.52) CDK2
SCHEMBL30142841 0.86 STAT3 (0.58) STAT3MEN1KMT2ANPC1RAB9A
SCHEMBL24074004 0.85 FBP1 (0.47) MEN1KMT2ALMNAMAPTALDH1A1
SCHEMBL30142663 0.85 FBP1 (0.47) MEN1KMT2ALMNAMAPTALDH1A1
SCHEMBL30142748 0.85 PRSS12 (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
CN-116472292-A Modified proteins and protein degrading agents 上海睿跃生物科技有限公司 2023-07-21 — — CN disclosed
EP-4157888-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS Cullgen (Shanghai), Inc. (CN) 2023-04-05 — — EP disclosed
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2023-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 STAT3 3224/4885TNF 4458/4885NOD2 2129/4885
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 STAT3 3224/4885TNF 4458/4885NOD2 2129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback